Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1969
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Difficult-to-Treat Rheumatoid Arthritis in Older Adults: Implications of Ageing for Managing Patients ; volume:39 ; number:11 ; day:15 ; month:9 ; year:2022 ; pages:841-849 ; date:11.2022
Drugs & aging ; 39, Heft 11 (15.9.2022), 841-849, 11.2022
- Urheber
-
Novella-Navarro, Marta
Balsa, Alejandro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40266-022-00976-5
- URN
-
urn:nbn:de:101:1-2023011721014896453249
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Novella-Navarro, Marta
- Balsa, Alejandro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Managing Difficult Conversation
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Managing Difficult Conversation
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Managing Difficult Conversation
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
New insights from a systematic review and meta-analysis on the treatment of difficult-to-treat rheumatoid arthritis
Efficacy and safety of current therapies for difficult-to-treat rheumatoid arthritis: a systematic review and network meta-analysis
Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registry
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis